Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Analysis of Liquidity Ratios 
Quarterly Data

Microsoft Excel LibreOffice Calc

Liquidity Ratios (Summary)

Abbott Laboratories, liquidity ratios (quarterly data)

Microsoft Excel LibreOffice Calc
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Current ratio 1.85 1.85 1.83 1.79 1.75 1.72 1.70 1.57 1.43 1.44 1.54 1.68 1.58 1.62 1.42 1.58 1.66 2.26 2.69 2.94 2.91
Quick ratio 1.21 1.28 1.25 1.19 1.16 1.14 1.01 0.93 0.83 0.88 0.93 0.98 0.94 1.03 1.00 0.94 1.04 1.67 2.02 2.13 2.01
Cash ratio 0.65 0.78 0.75 0.71 0.67 0.60 0.46 0.46 0.34 0.38 0.41 0.37 0.36 0.45 0.59 0.36 0.45 1.08 1.41 1.45 1.33

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Abbott Laboratories current ratio improved from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Abbott Laboratories quick ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Abbott Laboratories cash ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.

Current Ratio

Abbott Laboratories, current ratio calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Current assets 23,429  24,239  23,492  22,627  21,817  20,441  17,390  17,221  15,498  15,667  16,119  15,195  14,409  14,632  18,196  14,122  14,964  20,147  21,377  19,983  19,329 
Current liabilities 12,647  13,105  12,867  12,614  12,462  11,907  10,257  10,959  10,808  10,863  10,491  9,062  9,113  9,012  12,776  8,951  9,010  8,912  7,935  6,803  6,646 
Liquidity Ratio
Current ratio1 1.85 1.85 1.83 1.79 1.75 1.72 1.70 1.57 1.43 1.44 1.54 1.68 1.58 1.62 1.42 1.58 1.66 2.26 2.69 2.94 2.91
Benchmarks
Current Ratio, Competitors2
Anthem Inc. 1.36 1.47 1.48 1.49 1.57 1.55 1.59 1.64 1.53 1.65 1.70 1.64 1.61 1.56 1.54 1.52 1.49 1.55 1.51 1.65 1.64
Bristol-Myers Squibb Co. 1.32 1.52 1.47 1.54 1.56 1.58 1.67 1.47 1.66 1.60 3.83 3.88 1.93 1.61 1.53 1.40 1.52 1.55 1.59 1.59 1.60
CVS Health Corp. 0.88 0.88 0.94 0.95 0.93 0.91 0.95 0.98 0.99 0.94 0.92 0.95 0.95 1.03 2.44 2.34 2.37 1.02 1.05 1.09 1.08
Danaher Corp. 1.68 1.43 1.48 2.26 2.05 1.86 2.08 2.20 1.32 5.19 3.43 2.32 2.18 1.47 1.53 1.50 1.59 1.43 1.43 1.49 1.05
Intuitive Surgical Inc. 5.22 5.08 5.58 5.99 6.71 6.86 7.04 6.38 4.96 4.53 4.64 5.04 5.44 5.28 6.05 5.98 5.82 3.99 4.76 4.41 3.88
Medtronic PLC 2.89 2.65 2.10 2.16 1.87 2.13 2.75 2.77 2.67 2.59 2.36 2.56 2.46 2.28 2.43 2.40 1.64 1.75 1.77 2.35 2.98
UnitedHealth Group Inc. 0.78 0.79 0.77 0.77 0.74 0.74 0.82 0.84 0.75 0.69 0.70 0.67 0.73 0.73 0.69 0.75 0.71 0.73 0.70 0.72 0.71

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 23,429 ÷ 12,647 = 1.85

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Abbott Laboratories current ratio improved from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Quick Ratio

Abbott Laboratories, quick ratio calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Cash and cash equivalents 7,675  9,799  9,302  8,658  8,054  6,838  4,480  4,763  3,377  3,860  4,091  3,137  3,022  3,844  7,369  3,065  3,857  9,407  11,012  9,675  8,706 
Short-term investments 483  450  390  286  318  310  251  274  291  280  244  239  239  242  181  199  185  203  187  160  154 
Trade receivables, less allowances 7,179  6,487  6,405  6,113  6,096  6,414  5,649  5,140  5,292  5,425  5,450  5,548  5,345  5,182  5,271  5,192  5,356  5,249  4,800  4,633  4,510 
Total quick assets 15,337  16,736  16,097  15,057  14,468  13,562  10,380  10,177  8,960  9,565  9,785  8,924  8,606  9,268  12,821  8,456  9,398  14,859  15,999  14,468  13,370 
 
Current liabilities 12,647  13,105  12,867  12,614  12,462  11,907  10,257  10,959  10,808  10,863  10,491  9,062  9,113  9,012  12,776  8,951  9,010  8,912  7,935  6,803  6,646 
Liquidity Ratio
Quick ratio1 1.21 1.28 1.25 1.19 1.16 1.14 1.01 0.93 0.83 0.88 0.93 0.98 0.94 1.03 1.00 0.94 1.04 1.67 2.02 2.13 2.01
Benchmarks
Quick Ratio, Competitors2
Anthem Inc. 1.23 1.33 1.33 1.35 1.43 1.42 1.45 1.49 1.37 1.52 1.58 1.51 1.49 1.44 1.38 1.37 1.32 1.42 1.40 1.51 1.51
Bristol-Myers Squibb Co. 1.03 1.20 1.16 1.16 1.25 1.28 1.43 1.26 1.38 1.26 3.63 3.61 1.64 1.39 1.31 1.18 1.29 1.37 1.38 1.36 1.37
CVS Health Corp. 0.54 0.55 0.59 0.58 0.54 0.53 0.58 0.63 0.60 0.52 0.52 0.54 0.55 0.55 1.92 1.84 1.85 0.49 0.53 0.54 0.53
Danaher Corp. 1.08 0.89 0.93 1.67 1.51 1.36 1.52 1.59 0.92 4.68 2.99 1.78 1.58 0.88 0.92 0.91 0.97 0.87 0.89 0.94 0.64
Intuitive Surgical Inc. 4.40 4.34 4.66 5.12 5.76 5.96 5.93 5.40 4.00 3.75 3.80 4.15 4.53 4.56 5.28 5.20 5.15 3.51 4.25 3.84 3.36
Medtronic PLC 2.06 1.91 1.58 1.63 1.37 1.50 2.05 2.02 1.95 1.90 1.69 1.88 1.83 1.71 1.85 1.84 1.25 1.36 1.33 1.76 2.30
UnitedHealth Group Inc. 0.72 0.72 0.71 0.71 0.68 0.68 0.75 0.76 0.66 0.63 0.64 0.62 0.66 0.67 0.62 0.68 0.64 0.68 0.66 0.68 0.67

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 15,337 ÷ 12,647 = 1.21

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Abbott Laboratories quick ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.

Cash Ratio

Abbott Laboratories, cash ratio calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Cash and cash equivalents 7,675  9,799  9,302  8,658  8,054  6,838  4,480  4,763  3,377  3,860  4,091  3,137  3,022  3,844  7,369  3,065  3,857  9,407  11,012  9,675  8,706 
Short-term investments 483  450  390  286  318  310  251  274  291  280  244  239  239  242  181  199  185  203  187  160  154 
Total cash assets 8,158  10,249  9,692  8,944  8,372  7,148  4,731  5,037  3,668  4,140  4,335  3,376  3,261  4,086  7,550  3,264  4,042  9,610  11,199  9,835  8,860 
 
Current liabilities 12,647  13,105  12,867  12,614  12,462  11,907  10,257  10,959  10,808  10,863  10,491  9,062  9,113  9,012  12,776  8,951  9,010  8,912  7,935  6,803  6,646 
Liquidity Ratio
Cash ratio1 0.65 0.78 0.75 0.71 0.67 0.60 0.46 0.46 0.34 0.38 0.41 0.37 0.36 0.45 0.59 0.36 0.45 1.08 1.41 1.45 1.33
Benchmarks
Cash Ratio, Competitors2
Anthem Inc. 0.86 0.95 0.97 0.97 1.08 1.04 1.04 1.10 0.95 1.08 1.14 1.07 1.04 1.01 0.99 0.99 0.97 1.05 1.08 1.12 1.15
Bristol-Myers Squibb Co. 0.66 0.78 0.73 0.68 0.75 0.83 1.03 0.92 0.95 0.84 3.10 3.02 0.99 0.83 0.70 0.62 0.70 0.71 0.75 0.72 0.72
CVS Health Corp. 0.16 0.18 0.20 0.17 0.15 0.18 0.19 0.27 0.21 0.15 0.14 0.17 0.16 0.15 1.42 1.39 1.39 0.06 0.09 0.08 0.08
Danaher Corp. 0.49 0.32 0.35 1.07 0.93 0.82 0.94 0.99 0.52 4.04 2.40 1.08 0.84 0.16 0.17 0.20 0.24 0.13 0.15 0.17 0.13
Intuitive Surgical Inc. 3.58 3.66 3.98 4.42 5.04 5.30 5.27 4.85 3.44 3.13 3.11 3.37 3.79 3.73 4.46 4.40 4.33 2.78 3.49 3.04 2.62
Medtronic PLC 1.36 1.27 1.17 1.18 0.99 1.06 1.33 1.27 1.25 1.16 1.03 1.20 1.21 1.11 1.32 1.29 0.86 0.96 0.90 1.17 1.62
UnitedHealth Group Inc. 0.37 0.36 0.35 0.35 0.33 0.33 0.37 0.42 0.35 0.28 0.30 0.32 0.32 0.33 0.30 0.40 0.37 0.37 0.39 0.37 0.39

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 8,158 ÷ 12,647 = 0.65

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Abbott Laboratories cash ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.